We are live on ! Find out more
Norges Bank

Norges Bank Portfolio holdings

AUM $935B
 

Norges Bank, established in 1816 and headquartered in Oslo, Norway, serves as the central bank of Norway, responsible for monetary policy, issuing the Norwegian krone, and maintaining financial stability. Beyond its traditional central banking role, it oversees the management of the Government Pension Fund Global (often called the Norwegian Oil Fund), one of the world’s largest sovereign wealth funds, valued at over $1 trillion, which invests Norway’s oil and gas revenues in global equities, bonds, and real estate. The fund’s investment arm, Norges Bank Investment Management (NBIM), operates independently to ensure long-term wealth preservation for future generations, emphasizing sustainable and ethical investing practices. With its dual role, Norges Bank uniquely blends central banking duties with stewardship of a massive global investment portfolio.

This Fund
S&P 500
This Quarter Est. Return
+10.03%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$358B
AUM Growth
+$31.8B
Cap. Flow
+$2.34B
Cap. Flow %
0.65%
Top 10 Hldgs %
18.5%
Holding
2,137
New
45
Increased
503
Reduced
473
Closed
63

Sector Composition

Rank Sector Weight
1 Technology 19.16%
2 Financials 16.45%
3 Healthcare 13.43%
4 Consumer Discretionary 11.44%
5 Communication Services 9.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BF.A icon
2026
Brown-Forman Class A
BF.A
$13.7B
$958K ﹤0.01%
+15,267
New +$937K
REAL icon
2027
The RealReal
REAL
$1.41B
$943K ﹤0.01%
50,000
CSTE icon
2028
Caesarstone
CSTE
$69.5M
$940K ﹤0.01%
62,350
-65,833
-51% -$1.06M
CABA icon
2029
Cabaletta Bio
CABA
$427M
$908K ﹤0.01%
+65,000
New +$770K
BOLD
2030
DELISTED
Audentes Therapeutics, Inc
BOLD
$870K ﹤0.01%
14,536
-19,560
-57% -$734K
PRNB
2031
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
$864K ﹤0.01%
+15,769
New +$589K
RAPT
2032
DELISTED
RAPT Therapeutics
RAPT
$828K ﹤0.01%
+3,750
New +$690K
PD icon
2033
PagerDuty
PD
$830M
$819K ﹤0.01%
35,000
TVRD
2034
Tvardi Therapeutics
TVRD
$20.1M
$806K ﹤0.01%
1,389
SPT icon
2035
Sprout Social
SPT
$530M
$803K ﹤0.01%
+50,000
New +$812K
MDLA
2036
DELISTED
Medallia, Inc.
MDLA
$778K ﹤0.01%
25,000
KRRO icon
2037
Korro Bio
KRRO
$145M
$701K ﹤0.01%
+800
New +$622K
ZYME icon
2038
Zymeworks
ZYME
$1.62B
$695K ﹤0.01%
+15,292
New +$556K
APRE icon
2039
Aprea Therapeutics
APRE
$7.69M
$688K ﹤0.01%
+750
New +$413K
VIE
2040
DELISTED
Viela Bio, Inc. Common Stock
VIE
$679K ﹤0.01%
+25,000
New +$630K
AFYA icon
2041
Afya
AFYA
$1.35B
$678K ﹤0.01%
25,000
RVLV icon
2042
Revolve Group
RVLV
$1.85B
$645K ﹤0.01%
35,112
SI
2043
DELISTED
Silvergate Capital Corporation
SI
$636K ﹤0.01%
+40,000
New +$619K
BNFT
2044
DELISTED
Benefitfocus, Inc.
BNFT
$626K ﹤0.01%
28,533
-11,467
-29% -$260K
OYST
2045
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$611K ﹤0.01%
+25,000
New +$439K
ACOR
2046
DELISTED
Acorda Therapeutics
ACOR
$603K ﹤0.01%
2,462
-1,706
-41% -$430K
SKY icon
2047
Champion Homes
SKY
$4.41B
$577K ﹤0.01%
+18,205
New +$567K
TRUE
2048
DELISTED
TrueCar
TRUE
$547K ﹤0.01%
115,101
-866,714
-88% -$3.62M
DBVT
2049
DBV Technologies
DBVT
$813M
$535K ﹤0.01%
5,000
XYF
2050
X Financial
XYF
$193M
$532K ﹤0.01%
105,000

Similar funds

Norges Bank's Q4 2019 Portfolio in Review

As of Q4 2019, Norges Bank held 2,137 positions worth $358B, up 9.8% from $327B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Norges Bank's Q4 2019 filing shows 45 new, 503 increased, 473 reduced and 63 closed positions. Its largest new stake was Walmart Inc: 4,711,437 shares worth $187M. The largest sale was Celgene Corp, an estimated $783M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • Norges Bank's largest Q4 2019 buy was Walmart Inc: 4,711,437 shares worth $187M.
  • Norges Bank added most to Alibaba in Q4 2019, an estimated $713M increase.
  • Norges Bank's biggest Q4 2019 reduction was Morgan Stanley, cutting an estimated $196M.
  • Norges Bank fully exited Celgene Corp in Q4 2019, selling an estimated $783M.
  • Norges Bank's ten largest holdings make up 19% of its $358B portfolio in Q4 2019.
  • Norges Bank opened 45 new positions and closed 63 in Q4 2019.
  • Norges Bank's portfolio value rose 9.8% quarter-over-quarter to $358B.

Based on Norges Bank's 13F filing for Q4 2019, filed 12 Feb 2020.